Clinical Trial: A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV

U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07698600) titled 'A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV' on July 07.

Brief Summary: This study will test a new ribonucleic acid (RNA)-based vaccine called BNT168 in adults living both with and without human immunodeficiency virus (HIV), to see how safe it is, how well it triggers the body's immune response and how it affects the amount of virus in the body.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: HIV -1 Infection

Intervention: BIOLOGICAL: BNT168

Intramuscular injection to be applied in the deltoid muscle, using the same non-dom...